These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria. Bommelaer G, Dorval E, Denis P, Czernichow P, Frexinos J, Pelc A, Slama A, El Hasnaoui A. Gastroenterol Clin Biol; 2002 Dec; 26(12):1118-23. PubMed ID: 12520200 [Abstract] [Full Text] [Related]
7. Irritable bowel syndrome in a rural community in Bangladesh: prevalence, symptoms pattern, and health care seeking behavior. Masud MA, Hasan M, Khan AK. Am J Gastroenterol; 2001 May; 96(5):1547-52. PubMed ID: 11374697 [Abstract] [Full Text] [Related]
8. Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V. Aliment Pharmacol Ther; 2005 Jun 01; 21(11):1365-75. PubMed ID: 15932367 [Abstract] [Full Text] [Related]
12. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria. Han SH, Lee OY, Bae SC, Lee SH, Chang YK, Yang SY, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH, Kim TH. J Gastroenterol Hepatol; 2006 Nov 01; 21(11):1687-92. PubMed ID: 16984590 [Abstract] [Full Text] [Related]
13. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Hillilä MT, Färkkilä MA. Aliment Pharmacol Ther; 2004 Aug 01; 20(3):339-45. PubMed ID: 15274671 [Abstract] [Full Text] [Related]
14. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study. Yilmaz S, Dursun M, Ertem M, Canoruc F, Turhanoğlu A. Int J Clin Pract; 2005 Mar 01; 59(3):361-9. PubMed ID: 15857337 [Abstract] [Full Text] [Related]
15. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Paré P, Gray J, Lam S, Balshaw R, Khorasheh S, Barbeau M, Kelly S, McBurney CR. Clin Ther; 2006 Oct 01; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129 [Abstract] [Full Text] [Related]
16. Predictors of irritable bowel-type symptoms and healthcare-seeking behavior among adults with celiac disease. Häuser W, Musial F, Caspary WF, Stein J, Stallmach A. Psychosom Med; 2007 May 01; 69(4):370-6. PubMed ID: 17470666 [Abstract] [Full Text] [Related]
17. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease. De Vries DR, Van Herwaarden MA, Baron A, Smout AJ, Samsom M. Scand J Gastroenterol; 2007 Aug 01; 42(8):951-6. PubMed ID: 17613924 [Abstract] [Full Text] [Related]
18. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study. Brun-Strang C, Dapoigny M, Lafuma A, Wainsten JP, Fagnani F. Eur J Gastroenterol Hepatol; 2007 Dec 01; 19(12):1097-103. PubMed ID: 17998835 [Abstract] [Full Text] [Related]
20. Functional dyspepsia and irritable bowel syndrome in patients with achalasia and its association with non-cardiac chest pain and a decreased health-related quality of life. Frankhuisen R, Van Herwaarden MA, Heijkoop R, Baron A, Vermeijden R, Smout AJ, Gooszen HG, Samsom M. Scand J Gastroenterol; 2009 Dec 01; 44(6):687-91. PubMed ID: 19263270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]